Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
REGÍSTRESE
“I’m one of those people who has always wanted to solve puzzles. As a kid, I wanted to be the first to know something that no one else did. I think that’s true of a lot of scientists.” – James Allison
In the world of immunology, Dr. James P. Allison is something of a rock star. Not only has he made numerous fundamental discoveries about how T cells function, he also inaugurated the approach to cancer immunology known as checkpoint blockade, which is revolutionizing cancer treatment.
Claudia Dreifus of the New York Times sat down with Allison, who since 2011 has been director of CRI’s Scientific Advisory Council, to discuss cancer immunotherapy, growing up a science-loving kid in Texas, and once sharing a stage with Willie Nelson.
Photo copyright 2015, New York Times
Inmunoterapia vs. Quimioterapia: ¿Cual es la diferencia?
Read Next Article
Comuníquese con nosotros
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).